NEUROGENE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.35 USD | -1.40% |
|
+0.32% | +92.72% |
| Jun. 03 | Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program | MT |
| Jun. 03 | Neurogene Inc. Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for Start Pilot Program | CI |
- Stock Market
- Equities
- NGNE Stock
- News Neurogene Inc.
- MarketScreener Strategies
